Peers for comparison
1.01 USD
−144.34 M USD
4.02 B USD
47.38 M
Last report date
Report period
EPS
Revenue
Earnings release details
Q3 organic revenue rose 4.7% and non-GAAP EPS grew 27.2%, beating prior outlook. FY26 revenue and EPS guidance increased on improving demand, strong DSA bookings and manufacturing recovery.
Company info
Sector
CEO
Birgit Girshick
Website
Headquarters
Wilmington
Founded
1947
IPO date
Jun 23, 2000
ISIN
US1598641074
CUSIP
159864107
FIGI
BBG000BG5BL8
Identifiers
ISIN US1598641074
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The Research Models and Services segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The Discovery and Safety Assessment segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
DurchfallWe have been broken through the low of October/November 2023. In January we did not succeed yet but now we have managed to. Hopefully we can remain under this support until the end of February. But anyway the break is a short signal and the present attempt to retrace upward may be seen as healthy pr
CRL: bullish megaphone patternA bullish trend is applicable above 206.00
Further bullish confirmation for a break above 216.00
The target price is set at 224.00.
The stop-loss price is set at 202.00.
An incomplete bullish megaphone pattern is busy developing.
Furthermore testing its 200-day simple moving average as well as its 2
Charles River Labs is Leaking and now Sinking. CRLWe are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statisti
CRL offering an early entry with a pocket pivot?* Exceptional earnings
* Very strong up trend
* High RS in the Healthcare industry
* Pocket pivot occurring on the right side of a rounded constructive basing pattern
Trade Idea:
* You can get in now as indicated
* Or if you're looking for a slight discount you can look for an entry near the $423.6
CRL Short PredictionA very short prediction for CRL.............................................................................................................................................................................................................................................................................
Charles River Laboratories Q2 Profit, Revenue RiseStock suggested by my dad as one to watch. Nice strong upward trend with financials also headed in the right way.
Might be a bit expensive at the moment looking at the RSI, so on the watch list waiting for a bit of a pullback prior to any entry decisions.
Worth a look.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateMar 15, 2029
Coupon3.75% (Fixed)
Maturity dateMar 15, 2031
Coupon4.00% (Fixed)
Maturity dateMay 1, 2028
Coupon4.25% (Fixed)
See all CRL bonds
Frequently asked questions
Today, CRL trades at 337.97 USD.
For broader market analysis, dive into the technicals on the Charles River Laboratories International, Inc. stock price chart and read the latest CRL news:
– Charles River Strengthens Global Microbial Solutions Network Through Investments In Manufacturing, Customer Support, And Sustainability
– Charles River Laboratories International, Inc. (CRL) Expands Manufacturing and Service Capacity
– Charles River Strengthens Global Microbial Solutions Network Through Investments in Manufacturing, Customer Support, and Sustainability
For broader market analysis, dive into the technicals on the Charles River Laboratories International, Inc. stock price chart and read the latest CRL news:
– Charles River Strengthens Global Microbial Solutions Network Through Investments In Manufacturing, Customer Support, And Sustainability
– Charles River Laboratories International, Inc. (CRL) Expands Manufacturing and Service Capacity
– Charles River Strengthens Global Microbial Solutions Network Through Investments in Manufacturing, Customer Support, and Sustainability
Markets don't sleep, here's what's going on with CRL at the moment:
– Charles River Strengthens Global Microbial Solutions Network Through Investments In Manufacturing, Customer Support, And Sustainability
– Charles River Laboratories International, Inc. (CRL) Expands Manufacturing and Service Capacity
– Charles River Strengthens Global Microbial Solutions Network Through Investments in Manufacturing, Customer Support, and Sustainability
See more updates in real-time with our News Flow.
– Charles River Strengthens Global Microbial Solutions Network Through Investments In Manufacturing, Customer Support, And Sustainability
– Charles River Laboratories International, Inc. (CRL) Expands Manufacturing and Service Capacity
– Charles River Strengthens Global Microbial Solutions Network Through Investments in Manufacturing, Customer Support, and Sustainability
See more updates in real-time with our News Flow.
Charles River Laboratories International, Inc. is scheduled to release its next earnings report on Feb 24, 2027.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
CRL stock is 2.86% volatile and has beta coefficient of 1.39.
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like CRL are typically less volatile than smaller companies
Track every detail on Charles River Laboratories International, Inc. stock chart and check out the list of the most volatile stocks — is Charles River Laboratories International, Inc. there?
What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable
Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like CRL are typically less volatile than smaller companies
Track every detail on Charles River Laboratories International, Inc. stock chart and check out the list of the most volatile stocks — is Charles River Laboratories International, Inc. there?
To understand the CRL stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −0.83%
– 1 week — +6.04%
– 1 month — +13.59%
CRL all-time low was 17.19 USD (Dec 11, 2000), and its highest price is 460.21 USD (Sep 24, 2021). Find more dynamics in the Stock Heatmap and on the Charles River Laboratories International, Inc. stock chart.
– 1 day — −0.83%
– 1 week — +6.04%
– 1 month — +13.59%
CRL all-time low was 17.19 USD (Dec 11, 2000), and its highest price is 460.21 USD (Sep 24, 2021). Find more dynamics in the Stock Heatmap and on the Charles River Laboratories International, Inc. stock chart.
Charles River Laboratories International, Inc. market capitalization is 16.19 B, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Charles River Laboratories International, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Charles River Laboratories International, Inc. stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Charles River Laboratories International, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Charles River Laboratories International, Inc. stacks up against other companies
The safest way to buy Charles River Laboratories International, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade CRL directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade CRL directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 16, 2026, the company has 19.7 K employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Investing in Charles River Laboratories International, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study Charles River Laboratories International, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our CRL technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
First, study Charles River Laboratories International, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our CRL technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — buy
– 1-month — buy
Combine fundamental and technical analysis for better results.
Charles River Laboratories International, Inc. stock ticker depends on the exchange where it’s listed. On the NYSE, its primary exchange, Charles River Laboratories International, Inc. stocks trade under the symbol CRL.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
CRL earnings for the last quarter are 3.09 USD per share, whereas the estimation was 2.97 USD, resulting in a 3.94% surprise. The estimated earnings for the next quarter are 3.32 USD per share.
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in Charles River Laboratories International, Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one
Follow other essential metrics in Charles River Laboratories International, Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Charles River Laboratories International, Inc. revenue for the last quarter amounts to 982.73 M USD despite the estimated figure of 960.36 M USD. In the next quarter revenue is expected to reach 970.24 M USD.
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in Charles River Laboratories International, Inc. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance
Follow other essential metrics in Charles River Laboratories International, Inc. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track Charles River Laboratories International, Inc. financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
CRL net income for the last quarter is 333.07 M USD, while the quarter before that showed −1.48 M USD of net income which accounts for 22.57 K% change.
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Charles River Laboratories International, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result
Follow other essential metrics in Charles River Laboratories International, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, Charles River Laboratories International, Inc. does not currently pay dividends to its shareholders.
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.
What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
CRL reached its all-time high of 460.21 USD on Sep 24, 2021. Its all-time low was 17.19 USD and was reached on Dec 11, 2000.
Explore the Charles River Laboratories International, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the Charles River Laboratories International, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Charles River Laboratories International, Inc. EBITDA is 896.17 M USD, with an EBITDA margin of 22.89%.
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Charles River Laboratories International, Inc. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Charles River Laboratories International, Inc. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
Analyst forecasts suggest a price range between 302.00 USD and 400.00 USD for CRL, based on current estimates.
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance
Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions
Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance









